Identifying the risk of obstructive sleep apnea in metabolic syndrome patients: Diagnostic accuracy of the Berlin Questionnaire
Open Access
- 21 May 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (5) , e0217058
Abstract
Obstructive sleep apnea (OSA) is a risk factor frequently present in patients with metabolic syndrome (MetS). Additionally, moderate and severe OSA are highly prevalent in patients with cardiac disease, as they increase the riskfor cardiovascular events by 80%. The gold standard diagnostic method for OSA is overnight polysomnography (PSG), which remains unaffordable for the overall population. The aim of the present study was to evaluate whether the Berlin Questionnaire (BQ) is anuseful tool for assessing the risk of OSA in patients with MetS. 97 patients, previously untreated and recently diagnosed with MetS (National Cholesterol Education Program, Adult Treatment Panel III, ATP-III) underwent a PSG. OSA was characterized by the apnea-hypopnea index (AHI). BQ was administered before PSG and we evaluated sensitivity, specificity, positive and negative predictive values, and accuracy. Of the 97 patients with MetS, 81 patients had OSA, with 47 (48.5%) presenting moderate and severe OSA. For all MetS with OSA (AHI≥5 events/hour), the BQ showed good sensitivity (0.65, 95% CI 0.54 to 0.76) and fair specificity (0.38, 95% CI 0.15–0.65) with a positive predictive value of 0.84, a negative predictive value of 0.18 and an 84% accuracy. Similarly, for moderate-to-severe OSA (AHI≥15 events/hour) we found good sensitivity (0.73, 95% CI 0.58–0.85) and fair specificity (0.40, 95% CI 0.27–0.55). Interestingly, for severe OSA (AHI≥30 events/hour), there was a very good sensitivity (0.91, 95% CI 0.72–0.99) and moderate specificity (0.42, 95% CI 0.31–0.54). The BQ is a valid tool for screening the risk of OSA in MetS patients in general, and it is particularly useful in predicting severe OSA.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2015/03274-0 and #2016/16831-7)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Pesquisa (#309821/2014-2)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2013/15323-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2013/07651-7)
This publication has 36 references indexed in Scilit:
- Diagnostic Accuracy of the Berlin Questionnaire in Detecting Sleep-Disordered Breathing in Patients With a Recent Myocardial InfarctionChest, 2011
- Characteristics and Predictors of Obstructive Sleep Apnea in Patients With Systemic HypertensionThe American Journal of Cardiology, 2010
- Obstructive Sleep Apnea as a Risk Factor for Type 2 DiabetesThe American Journal of Medicine, 2009
- Obstructive Sleep Apnea Is Highly Prevalent and Correlates With Impaired Glycemic Control in Consecutive Patients With the Metabolic SyndromeJournal of the CardioMetabolic Syndrome, 2009
- Metabolic Syndrome: From Global Epidemiology to Individualized MedicineClinical Pharmacology & Therapeutics, 2007
- Metabolic syndrome in obstructive sleep apnea and related cardiovascular riskJournal of Cardiovascular Medicine, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Sleep apnea is a manifestation of the metabolic syndromeSleep Medicine Reviews, 2005
- Sympathetic neural mechanisms in obstructive sleep apnea.Journal of Clinical Investigation, 1995
- The Occurrence of Sleep-Disordered Breathing among Middle-Aged AdultsNew England Journal of Medicine, 1993